002675.SZ · 东诚药业
China A-shares · RS rating 89 · As of 2026-10-14
| Price | 13.87 CNY |
|---|---|
| 1-day change | +2.4% |
| RS rating (overall / 1M / 3M / 12M) | 89 / 93 / 79 / 58 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 30 / 28 / 31 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +9.0% |
| Distance from 52-week high | +13.5% |
| Market cap (USD) | $1.7B |